Unlock low-titer samples with superior sensitivity and robust performance
The Ion AmpliSeq SARS-CoV-2 Insight Research Assay leverages a unique targeted sequencing approach that yields improved coverage and uniformity from samples previously unobtainable by NGS. Incorporation of intelligent panel design provides an increased resilience to new mutations introduced within the viral genome. Integrated analysis tools enable automated consensus sequence generation, mutation annotation, and lineage assignment.
To learn more about the Ion AmpliSeq SARS-CoV-2 Insight Research Assay from one of our technical specialists and to request project costs, submit a request below.
Genome coverage and uniformity vs Ct value using the Ion AmpliSeq SARS-CoV-2 Insight Research Assay
Demonstrated >98% Reads on Target and coverage uniformity obtained from sequencing samples with low viral titer as indicated by real-time PCR results. Sample measurements represent N=2 and average Ct value was used in analysis. Libraries were generated using the Ion AmpliSeq SARS-CoV-2 Insight Research Assay manual preparation protocol and sequenced on a Ion 540 Chip. Data courtesy of Paris Demo Lab using nasopharyngeal swab samples from Laboratoire Départemental d'Analyses du Jura - Lda39.
For assay ordering information, select from the table below.
 | Ion AmpliSeq SARS-CoV-2 Insight Research Assay GS, manualConsists of the Ion AmpliSeq SARS-CoV-2 Insight Research Panel and Ion AmpliSeq Library Kit Plus reagents for those performing manual library preparation |
|
 | Ion AmpliSeq SARS-CoV-2 Insight Research Assay GS, Chef-readyConsists of the Ion AmpliSeq SARS-CoV-2 Insight Research Panel and the Ion AmpliSeq Kit for Chef DL8 for those utilizing the Ion Chef System for library preparation |
|
 | Ion AmpliSeq SARS-CoV-2 Insight Research Assay - GXThis assay is compatible with the Genexus Integrated Sequencer, which performs library preparation, sequencing, analysis, and reporting in an automated sample-to-result workflow |
|
Ion Torrent targeted next-generation sequencing (NGS) technology enables a streamlined research workflow for complete viral genome sequencing and variant detection for epidemiological studies of SARS-CoV-2.
The Ion AmpliSeq SARS-CoV-2 Insight Research Assay consists of two pools with amplicons ranging from 125 bp to 275 bp in length and covers >99% of the SARS-CoV-2 genome, including all serotypes. The assay is part of a fast, automated, and accurate targeted NGS workflow that enables coronavirus typing in under a day. This end-to-end solution includes the assay and plug-in suite that was developed in collaboration with researchers at the forefront of the SARS-CoV-2 crisis. Our complementary targeted NGS systems makes SARS-COV-2 epidemiology research accessible to any lab, regardless of your team’s current level of NGS expertise.
Learn about importance of targeted NGS for emerging research applications in SARS-CoV-2 epidemiology and transmission studies
Benefits of using Ion Torrent NGS for SARS-CoV-2 research:
- Rapid turnaround time
- Highly automated NGS workflow—for easier adoption, lower user intervention, and improved lab efficiency
- Accuracy of variants—lower substitution errors for SNVs
- Higher success rates—analyze samples directly with lower viral loads (as low as 20 copies)
Targeted NGS workflow for the Ion AmpliSeq SARS-CoV-2 Insight Research Assay
Complementary Ion Torrent NGS systems for SARS-CoV-2 research
Ion GeneStudio S5 Series
Scalable, targeted NGS workhorse with wide application breadth and throughput capability
- Higher-throughput scalability for cost-effective processing of a large number of research samples
- Perform assays for research of viral typing and epidemiology, immune response, microbiome analysis, and vaccines on the same platform
Learn more about SARS-CoV-2 research using the GeneStudio S5 Series System ›
Ion Torrent Genexus Integrated Sequencer
Go from nucleic acid to report in a single day with a hands-off, automated workflow*
- Hands-off, setup-and-go workflow with automated reverse transcription, library prep, template prep, sequencing, and analysis all on one instrument
- Perform assays for viral typing and epidemiology research and TCR sequencing
Learn more about SARS-CoV-2 research using the Genexus System ›
eBook: Advances in epidemiological research using NGS
Video: The importance of targeted NGS for SARS-CoV-2 epidemiology research
Application Note: Workflow and performance of the Ion AmpliSeq SARS-CoV-2 Insight Research Assay on the Genexus Sequencer
Application Note: SARS-CoV-2 research applications using the Ion GeneStudio S5 system
Application Note: Evaluation of SARS-CoV-2 sequencing performance using raw and stabilized saliva samples
Press Release: Rapid SARS-CoV-2 Genome Sequencing Aids Epidemiological Investigations
Press Release: Early Data Suggests SARS-CoV-2 is Slow Mutating; Potential for Vaccine Research
For Research Use Only. Not for use in diagnostic procedures.
